Project Grant R01DK138912
- This $171,639 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a "Multi-omic Investigation of Uremic Toxin Sources and Accumulation in Children with Kidney Failure" conducted by the Children's Hospital of Philadelphia (CHOP). The key objectives of this research project are to: 1) Characterize the contributions...
- This $166,740 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) aims to conduct research on the role of urinary phosphate in the progression of chronic kidney disease (CKD). The key activities under this 5-year award include: Defining how chronic phosphaturia (high urinary phosphate levels) impacts CKD progression in a mouse model. Determining if enhancing tubular phosphate...
- This Project Grant award, in the amount of $126,846, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a translational research project to investigate the role of the gut microbiome in the pathogenesis of sepsis-associated acute kidney injury (AKI). The research, to be conducted at the University of Michigan, aims to identify gut bacteria...
- This $809,427 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research on the impact of polymicrobial interactions and within-host adaptation on the pathogenesis of catheter-associated urinary tract infections (CAUTI). The award recipient, The Research Foundation For The State University Of New York (RF SUNY) doing business as Sponsored...
- The Cleveland Clinic Foundation will investigate the importance of the gut microbial endocrine organ in kidney cancer development and therapeutic response under a $585,798 project grant from the Department of the Army Medical Command. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield wounds...
- This $2,833,514 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, titled "Renal Metabolism in AKI", will fund research to investigate changes in kidney metabolism in sepsis-associated acute kidney injury (AKI) and their impact on kidney tubule injury and recovery. The University of California, San Diego (UCSD) is the awardee...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), totals $129,619 and will fund research on the interactions between the gut microbiome, intestinal development, and metabolic health in the context of fetal growth restriction (FGR). The overarching goal is to investigate how impaired intestinal and gut microbial development in FGR increases the...
- This federal Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to investigate the molecular mechanisms driving the transition from acute kidney injury (AKI) to chronic kidney disease (CKD). The $1,491,303 award to The Washington University aims to characterize how the repression of the FOXM1-CCNF axis during tubular epithelial...
- This federal Project Grant award of $799,952 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research at Northwestern University to investigate the role of the transcription factor HNF4A in the progression of chronic kidney disease (CKD) and associated complications such as inflammation, anemia, and bone/mineral disorders. The research aims...
- The Beckman Research Institute of the City of Hope received a $140,116 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, awarded on September 15, 2025, will support research to identify and characterize a mechanism of communication between the intestine and white adipose tissue via intestinal mTOR signaling. The goal is to understand how...
INTERSPECIES MICROBIAL INTERACTIONS IN CKD - ABSTRACT CHRONIC KIDNEY DISEASE (CKD) IS A GRADUAL LOSS OF KIDNEY FUNCTION, WHICH AFFECTS AN ESTIMATED 37 MILLION AMERICAN ADULTS, RESULTING IN 14.6 DEATHS PER 100,000 POPULATION. ONCE KIDNEY DAMAGE OCCURS, IT IMPAIRS REMOVAL OF UREMIC TOXINS, LEADING TO FURTHER DETERIORATION OF PHYSIOLOGICAL FUNCTIONS AND PROGRESSION OF RENAL FAILURE. SURPRISINGLY, MANY UREMIC TOXINS ARE NOT PRODUCED BY THE BODY ITSELF, BUT RATHER DERIVED FROM THE GUT MICROBIOTA. CKD IS ASSOCIATED WITH CHANGES IN THE COMPOSITION OF THE GUT MICROBIOTA (DYSBIOSIS), WHICH IS CHARACTERIZED BY AN INCREASED ABUNDANCE OF ENTEROBACTERIACEAE IN THE FECAL MICROBIOTA, A GROUP OF MICROBES KNOWN TO PRODUCE UREMIC TOXINS, SUCH AS INDOLE. THE OBJECTIVES OF THIS APPLICATION ARE TO UNDERSTAND THE ECOLOGICAL CAUSES OF DYSBIOSIS IN CKD ON A MOLECULAR LEVEL AND TO DETERMINE WHETHER DYSBIOSIS HAS A CAUSATIVE EFFECT ON CKD PROGRESSION. OUR CENTRAL HYPOTHESIS IS THAT ELEVATED EXPRESSION OF INDUCIBLE NITRIC OXIDE SYNTHASE (INOS) IN THE INTESTINE FUELS GROWTH OF ENTEROBACTERIACEAE BY ANAEROBIC NITRATE RESPIRATION. IN TURN, INCREASED INDOLE PRODUCTION BY RESPIRING ENTEROBACTERIACEAE AGGRAVATES CKD DISEASE PROGRESSION. WE WILL TEST DIFFERENT ASPECTS OF OUR HYPOTHESIS USING THE LOGICAL AND INNOVATIVE APPROACH OUTLINED IN THE FOLLOWING SPECIFIC AIMS. SPECIFIC AIM 1: DETERMINE THE ECOLOGICAL CAUSES OF DYSBIOSIS DURING CKD. SPECIFIC AIM 2: DETERMINE WHETHER DYSBIOSIS HAS A CAUSATIVE EFFECT ON CKD PROGRESSION. THE PROPOSED WORK IS INNOVATIVE BECAUSE IT IS AMONG THE FIRST TO PROVIDE MOLECULAR INSIGHTS INTO HOW CHANGES IN THE MICROBIOTA COMPOSITION OCCUR IN CKD, AND HOW MICROBIOTA CHANGES ARE CAUSATIVELY LINKED TO DISEASE PROGRESSION. SUCCESSFUL COMPLETION OF THE PROPOSED WORK WILL ESTABLISH HOW CKD-ASSOCIATED HOST RESPONSES DRIVE CHANGES IN THE ECOLOGY OF THE GUT MICROBIOTA, WHICH IN TURN SET THE STAGE FOR RELEASE OF UREMIC TOXINS BY ENTEROBACTERIACEAE, THUS ACCELERATING CKD PROGRESSION. THIS OUTCOME WILL BE OF BROAD SIGNIFICANCE FOR THE RATIONAL DESIGN OF NEW INTERVENTION STRATEGIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $689.8k | 6/10/25 | ||
| Not listed | $689.1k | 5/2/24 | ||
| Not listed | $689.1k | 5/2/24 |